AA amyloidosis of unknown aetiology: response to treatment with interleukin-1 inhibitors.
Ufuk İlgen, İsmail Uçar, Güner Kılıç, Orhan Küçükşahin
Author Information
- Ufuk İlgen: Rheumatology Clinic, Tatvan State Hospital, Bitlis, Turkey. ORCID
- İsmail Uçar: Rheumatology Clinic, Mersin City Hospital, Mersin, Turkey. ORCID
- Güner Kılıç: Department of Gastroenterology, Van Training and Research Hospital, Van, Turkey. ORCID
- Orhan Küçükşahin: Department of Rheumatology, Ankara Yıldırım Beyazıt University Medical School, Ankara, Turkey. ORCID
No abstract text available.
- Amyloid. 2015;22(2):84-92
[PMID: 25585627]
- Rheumatology (Oxford). 2014 Apr;53(4):665-70
[PMID: 24352339]
- Front Immunol. 2021 Feb 01;11:619257
[PMID: 33603750]
- Kidney Int. 2022 Feb;101(2):349-359
[PMID: 34560138]
- N Engl J Med. 2007 Jun 7;356(23):2361-71
[PMID: 17554117]
- Mod Rheumatol. 2019 Mar;29(2):363-366
[PMID: 29578360]
- Amyloid. 2017 Sep;24(3):189-193
[PMID: 28745926]
- Amyloid. 2017 Sep;24(3):162-166
[PMID: 28686088]
